IS THERE A MORTALITY BENEFIT WITH RENIN-ANGIOTENSIN SYSTEM (RAS) INHIBITION IN AFRICAN AMERICANS (AA) WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)? Conference

Valadri, Ravinder R, Veledar, Emir, Gadesam, Radhika et al. (2012). IS THERE A MORTALITY BENEFIT WITH RENIN-ANGIOTENSIN SYSTEM (RAS) INHIBITION IN AFRICAN AMERICANS (AA) WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)? . 59(13), E960-E960. 10.1016/S0735-1097(12)60961-9



cited authors

  • Valadri, Ravinder R; Veledar, Emir; Gadesam, Radhika; Cardona, Saumeth; Cross, Jo Ann; Strayhorn, Gregory; Bloom, Heather; Oduwole, Adefisayo; De Lurgio, David; Butler, Javed; Ofili, Elizabeth; Onwuanyi, Anekwe

fiu authors

date/time interval

  • March 24, 2012 -

publication date

  • March 27, 2012
  • March 24, 2012

keywords

  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • Life Sciences & Biomedicine
  • Science & Technology

Location

  • Chicago, IL

Digital Object Identifier (DOI)

Conference

  • 61st Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC)

start page

  • E960

end page

  • E960

volume

  • 59

issue

  • 13